95 results
8-K
KA
Kineta Inc
24 Apr 24
Entry into a Material Definitive Agreement
4:00pm
Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company is not in compliance with Nasdaq Listing Rule 5550(a)(2
8-K
EX-10.1
KA
Kineta Inc
5 Oct 23
Kineta, Inc. Announces $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:05pm
. Treasury Department (“OFAC”).
(kk)U.S. Real Property Holding Corporation. The Company is not and has never been a U.S. real property holding
424B5
qrhk hn8c7sen
5 Oct 23
Prospectus supplement for primary offering
10:47am
8-K
e7rahn65zkmb hndb
16 Aug 23
Other Events
4:00pm
8-K
klesi 2x7q7g6zvc6l
3 Jul 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9:31am
8-K
EX-99.1
p2kwxhibqxxj3io0ddck
11 May 23
Kineta Reports First Quarter 2023 Financial Results and Provides Corporate Update
5:20pm
8-K
EX-10.1
4vr3wq7fasw
21 Apr 23
Kineta, Inc. Announces $6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
5:16pm
8-K
EX-10.15
0ac5qyv
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-99.5
g9gw71 cmpm4
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-3.3
zn7b mkxeial
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-99.6
v877gj16tmwrg3v yl
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
424B3
8xu9eos
10 Nov 22
Prospectus supplement
4:21pm